Theseus Pharmaceuticals Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2014	FY 2013	FY 2012
Period Ending	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Cash & Equivalents	369.38	870.17	557.31
Short-Term Investments	10.02	13.01	0.62
Cash & Short-Term Investments	379.4	883.17	557.93
Cash Growth	-57.04%	58.29%	-
Accounts Receivable	1,116	3,077	811.46
Other Receivables	240.7	85.81	209.02
Receivables	1,357	3,163	1,120
Inventory	3,226	1,278	-
Prepaid Expenses	27.14	14.88	10.53
Other Current Assets	77.44	48.59	441.74
Total Current Assets	5,066	5,388	2,131
Property, Plant & Equipment	1,361	1,504	1,606
Long-Term Investments	1.5	-	-
Goodwill	0	0	0
Other Intangible Assets	7.86	10.26	11.74
Long-Term Deferred Charges	1,660	1,563	1,746
Other Long-Term Assets	70.81	39.42	38.59
Total Assets	8,168	8,504	5,533
Accounts Payable	889.78	1,381	996.47
Accrued Expenses	274.99	259.41	176.97
Short-Term Debt	3,586	4,000	431.18
Current Income Taxes Payable	19.9	-	-
Other Current Liabilities	611.18	241.82	396.15
Total Current Liabilities	5,382	5,883	2,001
Long-Term Debt	400	400	3,585
Other Long-Term Liabilities	138.09	72.37	-
Total Liabilities	6,178	6,665	5,915
Common Stock	800	800	800
Additional Paid-In Capital	6,015	6,015	4,095
Retained Earnings	-5,159	-5,311	-4,037
Treasury Stock	-	-	-1,495
Comprehensive Income & Other	-	-	0
Total Common Equity	1,656	1,504	-636.61
Shareholders' Equity	1,991	1,839	-381.61
Total Liabilities & Equity	8,168	8,504	5,533
Total Debt	3,986	4,400	4,016
Net Cash (Debt)	-3,607	-3,517	-3,458
Net Cash Per Share	-1857.03	-1863.00	-1825.85
Filing Date Shares Outstanding	1.94	1.89	1.89
Total Common Shares Outstanding	1.94	1.89	1.89
Working Capital	-315.84	-495.05	129.91
Book Value Per Share	852.45	796.82	-336.09
Tangible Book Value	1,648	1,494	-648.35
Tangible Book Value Per Share	848.40	791.38	-342.29
Land	213.85	213.85	213.85
Buildings	1,183	1,183	1,183
Machinery	1,334	1,111	917.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.